Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Optimization and High-level Expression of a Functional GST-tagged rHLT-B in Escherichia coli and GM1 Binding Ability of Purified rHLT-B

  • Ma Xingyuan (State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology) ;
  • Zheng Wenyun (State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology) ;
  • Wang Tianwen (State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology) ;
  • Wei Dongzhi (State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology) ;
  • Ma Yushu (State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology)
  • Published : 2006.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The Escherichia coli heat-labile enterotoxin B subunit (HLT-B) is one of the most powerful mucosal immunogens and known mucosal adjuvants. However, the induction of high levels of HLT-B expression in E. coli has proven a difficult proposition. Therefore, in this study, the HLT-B gene was cloned from pathogenic E. coli and expressed as a fusion protein with GST (glutathion S-transferase) in E. coli BL2l (DE3), in an attempt to harvest a large quantity of soluble HLT-B. The culture conditions, including the culture media used, temperature, pH and the presence of lactose as an inducer, were all optimized in order to obtain an increase in the expression of soluble GST-rHLT-B. The biological activity of the purified rHLT-B was assayed in a series of GMI-ELISA experiments. The findings of these trials indicated that the yield of soluble recombinant GST-rHLT-B could be increased by up to 3-fold, as compared with that seen prior to the optimization, and that lactose was a more efficient alternative inducer than IPTG. The production of rHLT-B, at 92 % purity, reached an optimal level of 96 mg/l in a 3.7 L fermentor. The specific GM1 binding ability of the purified rHLT-B was determined to be almost identical to that of standard CTB.

Keywords

References

  1. Bernardez, E. and D. Clark. 1998. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9, 157-163 https://doi.org/10.1016/S0958-1669(98)80109-2
  2. Birgit, W, H. Karin, R. Christian, W Stefan, B. Karin, S. Otto, W. Ursula, and B. Heimo. 2004. Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant. J. Immunol. Methods 287, 203- 215 https://doi.org/10.1016/j.jim.2004.02.001
  3. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 https://doi.org/10.1016/0003-2697(76)90527-3
  4. Donovan, R.S., C.W. Robinson, and B.R Glick. 1996. Optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J. Ind. Microbiol. 16, 145-154 https://doi.org/10.1007/BF01569997
  5. Frangioni, J.V. and B.G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210, 179-187 https://doi.org/10.1006/abio.1993.1170
  6. Gupta, J.C., G. Pandey, and K.J. Mukherjee. 2001. Two-stage cultivation of recombinant Saccharomyces cerevisiae to enhance plasmid stability under non-selective conditions: experimental study and modeling. Enzyme Microb. Technol. 28, 89-99 https://doi.org/10.1016/S0141-0229(00)00285-4
  7. Hashiguchi. K., H. Ogawa, and T. Ishidate. 1996. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 14, 113-114 https://doi.org/10.1016/0264-410X(95)00174-Y
  8. Hellman, J., P. Lassila, and P. Maentsae1ae. 1995. In vitro refolding of cyclomaltodextrin glucanotransferase from cytoplasmic inclusion bodies formed upon expression in Escherichia coli. Protein Expr. Purif. 6, 56-62 https://doi.org/10.1006/prep.1995.1008
  9. Kilikian, B.Y., LD. Suarez, C.w. Liria, and A.K. Gombert. 2000. Process strategies to improve heterologous protein production in Escherichia coli under lactose or IPTG induction. Proc. Biochem. 35, 1019-1025
  10. Menzella, H.G., E.A. Ceccarelli, and H.C. Gramajo. 2003. Novel Escherichia coli strain allows efficient recombinant protein production using lactose as inducer. Biotechnol. Bioeng. 82, 809-817 https://doi.org/10.1002/bit.10630
  11. Millar, D.G., TR. Hirst, and D.P. Snider. 2001. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its closely related homologue, the B subunit of cholera toxin. Infect. Immun. 69, 3476-3482 https://doi.org/10.1128/IAI.69.5.3476-3482.2001
  12. Mohammad, A.R., R. Abbas, M.M. Seyed, H.S. Ali, Y. Yoko, T Kunio, N.P. Shahin, and A. Mohsen. 2005. Expression of Escherichia coli Heat-labile Enterotoxin B Subunit (LTB) in Saccharomyces cerevisiae. J. Microbial. 43, 354-360
  13. Nashar, T.O., H.M. Webb, S. Eaglestone, N.A. Williams, and T.R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA 93, 226-230
  14. Richards, C.M., A.T Arnan, TR. Hirst, TJ. Hill, and N.A. Williams. 2001. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 75, 1664-1671 https://doi.org/10.1128/JVI.75.4.1664-1671.2001
  15. Sambrook, land D.W. Russell. 2001. Molecular cloning: a laboratory manual, 3th ed.: p16-34. Cold Spring Harbor Laboratory Press, New York
  16. SivaKesava, S., Z.N. Xu, Y.H. Chen, J. Hackett, R.C. Huang and E. Lam. 1999. Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system. Process Biochem. 34, 893-900 https://doi.org/10.1016/S0032-9592(99)00013-8
  17. Sixma, T.K., S.E. Pronk, K.H. Kalk, B.A. van Zanten, A.M. Berghuis, and W.G. Hol. 1992. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography. Nature 355, 561-564 https://doi.org/10.1038/355561a0
  18. Tamura, S., A. Yajima, and E. Hatori. 1997. Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection. Vaccine 15, 1784-1790 https://doi.org/10.1016/S0264-410X(97)00113-8
  19. Thomas, J.G. and F. Baneyx. 1996. Protein misfolding and inclusion body formation in recombinant Escherichia coli cells overexpressing heat-shock proteins. J. Biol. chem. 271, 11141-11147 https://doi.org/10.1074/jbc.271.19.11141
  20. Xu, Z.N., L. Gang, P.L. Cen, and K.R. Wong. 2000. Factors influencing secretive production of human epidermal growth factor (hEGF) with recombinant E. coli K12. Bioprocess Eng. 23, 669-674 https://doi.org/10.1007/s004490000218
  21. Yildirim, N. and M.C. Mackey. 2003. Feedback regulation in the lactose operon: a mathematical modeling study and comparison with experimental data. Biophys. J. 84, 2841-2851 https://doi.org/10.1016/S0006-3495(03)70013-7